High Quality Content by WIKIPEDIA articles! Pegylated interferon alfa-2b is a treatment for hepatitis C developed by Schering-Plough, brand name is Peg Intron. It was approved in January 2001. PEG-interferon alpha is a pegylated interferon composed of 165 amino acids. The PEG (polyethylene glycol) protects the molecule from proteolytic breakdown and increases the biological half-life of the interferon protein. While PEG-interferon alpha-2b is commonly used as a treatment for hepatitis C, it has also been shown to have optimistic effects in the treatment of malignant melanoma. It is also used in patients with neurofibromatosis to shrink neurofibromas.
Bitte wählen Sie Ihr Anliegen aus.
Rechnungen
Retourenschein anfordern
Bestellstatus
Storno